一项随机对照试验:孕妇对片剂干预促进安全行为的态度和经验卡塔尔世界杯8强波胆分析定性研究%A Walter,Bente %A Indreboe,Hege %A Lukasse,Mirjam %A Henriksen,Lena %A Garnweidner-Holme,Lisa %+奥斯陆城市大学护理与健康促进系，St Olavs Plass, PO Box 4, Oslo, 0130, Norway, 47 +4748091956, lgarnwei@oslomet.no %K亲密伴侣暴力%K eHealth %K妊娠%K产前保健，安全行为%K片干预%D 2021 %7 20.7.2021 %9原文%J JMIR Form Res %G English %X亲密伴侣暴力被认为是一个全球性的健康问题。受教育程度低、资源有限的女性更容易受到伤害，移民女性也是如此。关于卫生保健专业人员应如何就怀孕期间的IPV进行沟通和干预，缺乏证据。早期的研究表明，当女性管理数字问卷时，她们更有可能披露IPV。然而，人们对妇女如何通过电子健康干预和安全行为来预防IPV知之甚少。目的:通过一项随机对照试验(RCT)，探讨孕妇在产前护理中对片剂干预促进安全行为的态度和体验。方法:对参加安全妊娠研究的10名妇女进行了单独的半结构化访谈。安全妊娠研究是一项随机对照试验(RCT)，使用含有IPV问题的片剂干预和电影来促进安全行为。 Six women from the intervention group and four women from the control group were recruited. The content was available in Norwegian, Somali, and Urdu. Five of the women participating in the interviews spoke Norwegian at home and five spoke another language. The majority of the women who did not speak Norwegian at home perceived themselves as relatively well integrated. The interviews were conducted at different maternal and child health centers (MCHCs) in Norway between March 2020 and June 2020. The analysis was guided by thematic analysis. Results: Women who participated in the tablet intervention appreciated being asked questions about IPV on a tablet. However, it was important to supplement the tablet intervention with face-to-face communication with a midwife. The MCHC was regarded as a suitable place to answer questions and watch a film about safety behaviors. Women suggested making the tablet intervention available in other settings where women meet health care professionals. Some women expressed uncertainty about their anonymity regarding their answers in the questionnaire. We found no real differences between ethnic Norwegian and immigrant women’s attitudes toward and experiences with the tablet intervention. Conclusions: Questions about IPV and a film about safety behaviors on a tablet, as a supplement to face-to-face communication, might initiate and facilitate communication about IPV in antenatal care. Uncertainty regarding anonymity has to be addressed when questions about IPV are being asked on a tablet. Trial Registration: ClinicalTrials.gov NCT03397277; https://clinicaltrials.gov/ct2/show/NCT03397277 %M 34283023 %R 10.2196/28680 %U https://formative.www.mybigtv.com/2021/7/e28680 %U https://doi.org/10.2196/28680 %U http://www.ncbi.nlm.nih.gov/pubmed/34283023